Thomas Hudson

Thomas Hudson has over a decade of experience in the biomedical research field, currently serving as a Research Scientist in Inflammation at Gilead Sciences since November 2017, following a progression from Associate Scientist to Senior Associate Scientist. Prior to Gilead Sciences, Thomas worked at Aduro Biotech as an Associate Scientist and Senior Research Associate from August 2015 until the company's merger with Chinook Therapeutics, Inc. Previously, positions included Research Associate at Novo Nordisk and Research Assistant at the Infectious Disease Research Institute, where Thomas led vaccine development projects. Earlier career experiences include managing projects on innate immunology at the University of Washington and roles at Brigham and Women's Hospital and the World Health Organization focusing on health impacts of climate change and related diseases. Thomas holds a Bachelor of Arts in Biology from Boston University.